Microbot Medical Stock Current Valuation
| MBOT Stock | USD 0.97 0.02 2.02% |
Valuation analysis of Microbot Medical helps investors to measure Microbot Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value is likely to gain to about 28.5 M in 2024, whereas Enterprise Value Over EBITDA is likely to drop (1.43) in 2024. Fundamental drivers impacting Microbot Medical's valuation include:
Price Book 4.322 | Enterprise Value 12.2 M | Enterprise Value Ebitda (0.89) |
Undervalued
Today
Please note that Microbot Medical's price fluctuation is unstable at this time. Calculation of the real value of Microbot Medical is based on 3 months time horizon. Increasing Microbot Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Microbot Medical's intrinsic value may or may not be the same as its current market price of 0.97, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.97 | Real 2.68 | Target 8.0 | Hype 0.95 | Naive 1.02 |
The intrinsic value of Microbot Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Microbot Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Microbot Medical helps investors to forecast how Microbot stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Microbot Medical more accurately as focusing exclusively on Microbot Medical's fundamentals will not take into account other important factors: Microbot Medical Company Current Valuation Analysis
Microbot Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Microbot Medical Current Valuation | 12.21 M |
Most of Microbot Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Microbot Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Microbot Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Microbot Medical is extremely important. It helps to project a fair market value of Microbot Stock properly, considering its historical fundamentals such as Current Valuation. Since Microbot Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Microbot Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Microbot Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Microbot Medical has a Current Valuation of 12.21 M. This is 99.91% lower than that of the Health Care Equipment & Supplies sector and 99.87% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.93% higher than that of the company.
Microbot Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Microbot Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Microbot Medical could also be used in its relative valuation, which is a method of valuing Microbot Medical by comparing valuation metrics of similar companies.Microbot Medical is currently under evaluation in current valuation category among its peers.
Microbot Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Microbot Medical from analyzing Microbot Medical's financial statements. These drivers represent accounts that assess Microbot Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Microbot Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 43.4M | 49.0M | 53.3M | 21.9M | 16.7M | 15.9M | |
| Enterprise Value | 15.5M | 30.2M | 40.5M | 19.9M | 14.5M | 28.5M |
Microbot Fundamentals
| Return On Equity | -1.34 | ||||
| Return On Asset | -0.65 | ||||
| Current Valuation | 12.21 M | ||||
| Shares Outstanding | 16.93 M | ||||
| Shares Owned By Insiders | 1.42 % | ||||
| Shares Owned By Institutions | 7.46 % | ||||
| Number Of Shares Shorted | 586.82 K | ||||
| Price To Earning | (3.42) X | ||||
| Price To Book | 4.32 X | ||||
| EBITDA | (10.63 M) | ||||
| Net Income | (10.74 M) | ||||
| Cash And Equivalents | 9.29 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 231 K | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 5.60 X | ||||
| Book Value Per Share | 0.38 X | ||||
| Cash Flow From Operations | (8.53 M) | ||||
| Short Ratio | 2.65 X | ||||
| Earnings Per Share | (0.79) X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 21 | ||||
| Beta | 1.63 | ||||
| Market Capitalization | 16.46 M | ||||
| Total Asset | 8.33 M | ||||
| Retained Earnings | (79.5 M) | ||||
| Working Capital | 4.13 M | ||||
| Current Asset | 15.21 M | ||||
| Current Liabilities | 9.83 M | ||||
| Net Asset | 8.33 M |
About Microbot Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Microbot Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Microbot Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Microbot Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.